CASI
CASI Pharmaceuticals Inc
NASDAQ: CASI · HEALTHCARE · BIOTECHNOLOGY
$0.21
+0.00% today
Updated 2026-06-05
Market cap
$3.21M
P/E ratio
—
P/S ratio
0.12x
EPS (TTM)
$-3.02
Dividend yield
—
52W range
$0 – $3
Volume
7.4M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$4.00
+1827.71%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
Insufficient data
Risks
- Thin margins at -184.00%
- Revenue declining -60.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $30.17M | $43.11M | $33.88M | $28.54M | $26.85M |
| Net income | $-36.65M | $-41.01M | $-26.94M | $-39.26M | $-10.88M |
| EPS | — | — | — | — | $-3.02 |
| Free cash flow | $-42.34M | $-26.70M | $-22.21M | $-29.46M | — |
| Profit margin | -121.50% | -95.14% | -79.51% | -137.57% | -184.00% |
Peer comparison
Smart narrative
CASI Pharmaceuticals Inc trades at $0.21. Our Smart Value Score of 24/100 indicates the stock is weak. TTM revenue stands at $26.85M. with profit margins at -184.00%.
Frequently asked questions
What is CASI Pharmaceuticals Inc's stock price?
CASI Pharmaceuticals Inc (CASI) trades at $0.21, on a P/S of 0.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is CASI Pharmaceuticals Inc overvalued?
CASI Pharmaceuticals Inc carries a Smart Value Score of 24/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of CASI Pharmaceuticals Inc (CASI)?
The 12-month analyst consensus target is $4.00, about 1827.7% above the current $0.21. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is CASI Pharmaceuticals Inc's revenue?
CASI Pharmaceuticals Inc's trailing twelve-month revenue is $26.85M. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryChina
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.12x
ROE-1,095.00%
Beta0.89
50D MA$0.83
200D MA$1.38
Shares out0.02B
Float0.01B
Short ratio—
Avg volume7.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—